tiprankstipranks
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
Want to see TVRD full AI Analyst Report?

Compare Tvardi Therapeutics (TVRD) vs. Competitors

2,520 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Tvardi Therapeutics
$3.39
$33.21M
-1.38
-86.76%
3 Buy
2 Hold
1 Sell
Moderate Buy
Plus Therapeutics
$0.58
$43.23M
-1.74
-61.10%
4 Buy
1 Hold
0 Sell
Strong Buy
Cue Biopharma
$0.34
$97.17M
5.20
32.21%
Aligos Therapeutics
$6.68
$39.85M
-1.22
15.00%
3 Buy
0 Hold
0 Sell
Strong Buy
Genenta Science SpA Sponsored ADR
$1.45
$16.22M
-2.51
-82.79%
Adlai Nortye Ltd. Sponsored ADR
$16.01
$598.80M
675.65%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TVRD
Tvardi Therapeutics
3.54
-22.46
-86.38%
PSTV
Plus Therapeutics
6.30
-7.79
-55.29%
CUE
Cue Biopharma
29.85
6.80
29.49%
ALGS
Aligos Therapeutics
6.44
2.08
47.71%
GNTA
Genenta Science SpA Sponsored ADR
0.69
-3.39
-83.04%
ANL
Adlai Nortye Ltd. Sponsored ADR
14.97
13.09
696.28%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts